Lung cancer in Victoria: Are we making progress?

Medical Journal of Australia

Volumn 199, Issue 10, 2013, Pages 674-679

  Mitchell, Paul L R ^a   Thursfield, Vicky J ^b   Ball, David L ^c   Richardson, Gary E ^d   Irving, Louis B ^e   Torn Broers, Yvonne ^b   Giles, Graham G ^b   Wright, Gavin M ^f  

^a AUSTIN HEALTH   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d CABRINI HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; RURAL AREA; SCORING SYSTEM; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; URBAN AREA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HEALTH SURVEYS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SMOKING; VICTORIA;

EID: 84887684478     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10331     Document Type: Article

References (25)

1. Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2008. Canberra: AIHW, 2008. (AIHW Cat. No. CAN 42; Cancer Series No. 46.)
2. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: an overview 2012. Canberra: AIHW, 2012. (AIHW Cat No. CAN 70; Cancer Series No 74.)
3. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-138.
4. Richardson GE, Thursfield VJ, Giles GG. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust 2000; 172: 321-324.
5. Ball DL, Irving LB. Are patients with lung cancer the poor relations in oncology? [comment] Med J Aust 2000; 172: 310-311.
6. Mac Manus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001; 92: 886-895.
7. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008; 26: 3552-3559.
8. Aupérin A, Le Péchoux C, Rolland E, et al. Metaanalysis of concomitant versus sequential radiochemotherapy in locally advanced nonsmall-cell lung cancer. J Clin Oncol 2010; 28: 2181-2190.
9. Colinet B, Jacot W, Bertrand D, et al. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 2005; 93: 1098-1105.
10. Vinod SK, O'Connell DL, Simonella L, et al. Gaps in optimal care for lung cancer. J Thorac Oncol 2008; 3: 871-879.
11. Longo DL, Fauci AS, Kasper DL, et al. Harrison's principles of internal medicine. 18th ed. Sydney: McGraw Hill Medical, 2013: 55.
12. Coory M, Fong K, Bowman R, Hall L. Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland. Intern Med J 2006; 36: 389-392.
13. Stevens W, Stevens G, Kolbe J, Cox B. Lung cancer in New Zealand: patterns of secondary care and implications for survival. J Thorac Oncol 2007; 2: 481-493.
14. Health and Social Care Information Centre, National Lung Cancer Audit. National Lung Cancer Audit Report 2012. Leeds, UK: HSCIC, 2012. http://www.hqip.org.uk/assets/NCAPOPLibrary/NCAPOP-2012-13/Lung-Cancer-National-Audit-Report-pub-2012.pdf (accessed Sep 2013).
15. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001; 56: 212-217.
16. Department of Health. Cancer Service Performance Indicators Report 2012. Melbourne: State Government of Victoria, 2012.
17. Boxer MM, Vinod SK, Shafiq J, Duggan KJ. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer 2011; 117: 5112-5120.
18. Arriagada R, Bergman B, Dunant A, et al; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-360.
19. Jacob S, Hovey E, Ng W, et al. Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care. Lung Cancer 2010; 69: 307-314.
20. Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 2003; 4: 120-128.
21. Pignon JP, Arriagada R, Ihde DC, et al. A metaanalysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618-1624.
22. Adair T, Hoy D, Dettrick Z, Lopez AD. Reconstruction of long-term tobacco consumption trends in Australia and their relationship to lung cancer mortality. Cancer Causes Control 2011; 22: 1047-1053.
23. Steinfort DP, Hew MJ, Irving LB. Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital. Intern Med J 2011; 41: 815-824.
24. Cancer Council Victoria. Cancer Survival Victoria 2012. Melbourne: Cancer Council Victoria, 2012: 36. www.cancervic.org.au/downloads/cec/cancer-survival-victoria-2012.pdf (accessed Sep 2013).
25. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011; 365: 395-409.